Inalways Corp is a Taiwan-based company mainly engaged in medical biotechnology and other businesses. The Company's main products include prescription drugs, indicated drugs, medical equipment, and food and health products. The Company also engages in health screening. The Company mainly operates in the Taiwan market.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
30/10/26	NT$16.35	-0.91%	74,167
29/10/26	NT$16.50	-0.90%	44,124
28/10/26	NT$16.65	-2.06%	96,355
27/10/26	NT$17.00	+0.89%	141,900

End-of-day quote Taipei Exchange

More quotes

End-of-day quote Taipei Exchange 30/10/2026			5-day change	1st Jan Change
16.35 ^TWD	-0.91%		-2.97%	-37.12%

08-13	Mediera Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-14	Mediera Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	809M 24.79M 22.2M 20.42M 18.5M 34.58M 2.35B 35.23M 243M 97.75M 1.24B 93.02M 91.04M 3.9B	P/E 2024	92.6x	P/E 2025	74.3x
Enterprise Value	710M 21.75M 19.48M 17.92M 16.24M 30.35M 2.07B 30.92M 214M 85.78M 1.09B 81.63M 79.89M 3.43B	EV / Sales 2024	3.69x	EV / Sales 2025	5.16x
Free-Float	53.64%	Yield 2024 *	-	Yield 2025	-

08-13	Mediera Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-14	Mediera Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-06	Mediera Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-14	Mediera Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11/08/25	Mediera Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
05/05/25	Mediera Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
26/03/25	Mediera Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
13/11/24	Mediera Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
14/08/24	Mediera Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Mediera Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
06/03/24	Mediera Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
10/11/23	Mediera Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
11/08/23	Mediera Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

1 day	-0.91%
1 week	-2.97%
1 month	+18.05%
3 months	+15.55%
6 months	-19.06%
Current year	-37.12%

Mediera Corporation Share Price

Stocks

5398

TW0005398002

Biotechnology & Medical Research

Valuation: Mediera Corporation

Chart: Mediera Corporation

Latest news: Mediera Corporation

Quotes and Performance

Price Extremes

Managers and Directors: Mediera Corporation

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

1 week	16.1	17.85
1 month	13.6	18.9
Current year	13.6	26.15
1 year	13.6	31
3 years	11	31
5 years	11	31
10 years	11	48.5

Manager	Title	Age	Since
Hsu Jen Huang CEO	Chief Executive Officer	-	27/06/2017
Hung Qin Peng DFI	Director of Finance/CFO	-	30/06/2016

Director	Title	Age	Since
Hsu Jen Huang CHM	Chairman	-	09/08/2019
Pin Yi Wu BRD	Director/Board Member	-	-
Te Lun Tang BRD	Director/Board Member	-	01/03/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEDIERA CORPORATION	-0.91%	-2.97%	-14.40%	+47.30%	24.79M
WUXI APPTEC CO., LTD.	-0.62%	-1.87%	+42.87%	+64.15%	63.77B
ARGENX SE	+0.35%	+3.20%	+14.40%	+81.76%	56.37B
LONZA GROUP AG	+0.53%	+1.96%	+16.24%	+103.35%	54.62B
IQVIA HOLDINGS INC.	-2.81%	-4.31%	+23.50%	+47.83%	44.06B
BEONE MEDICINES AG	-0.33%	-1.93%	+19.28%	+98.80%	42.11B
REVOLUTION MEDICINES, INC.	+0.55%	+2.31%	+225.14%	+866.21%	41B
GENMAB A/S	+3.27%	+47.96%	+112.84%	+96.58%	34.92B
CELLTRION, INC.	+1.22%	-1.44%	+14.57%	+46.95%	32.82B
INSMED INCORPORATED	+0.89%	+20.55%	-40.62%	+349.24%	24.7B
Average	+0.21%	+6.49%	+41.38%	+180.22%	39.44B
Weighted average by Cap.	+0.18%	+5.44%	+47.99%	+176.66%

	2024	2025
Net sales	238M 7.31M 6.55M 6.02M 5.46M 10.2M 694M 10.39M 71.8M 28.82M 365M 27.43M 26.85M 1.15B	230M 7.04M 6.31M 5.8M 5.26M 9.83M 669M 10.01M 69.2M 27.78M 352M 26.44M 25.87M 1.11B
Net income	10.44M 320K 286K 263K 239K 446K 30.37M 455K 3.14M 1.26M 15.97M 1.2M 1.17M 50.37M	17.36M 532K 476K 438K 397K 742K 50.51M 756K 5.23M 2.1M 26.57M 2M 1.95M 83.79M
Net Debt	-83.1M -2.55M -2.28M -2.1M -1.9M -3.55M -242M -3.62M -25.02M -10.04M -127M -9.56M -9.35M -401M	-99.01M -3.03M -2.72M -2.5M -2.26M -4.23M -288M -4.31M -29.81M -11.97M -152M -11.39M -11.14M -478M